These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2141018

  • 1. In-vitro activities of trospectomycin, cefpodoxime, and second-generation cephalosporins against Haemophilus influenzae type b.
    LiPuma JJ, Daley B, Stull TL.
    J Antimicrob Chemother; 1990 Apr; 25(4):535-9. PubMed ID: 2141018
    [Abstract] [Full Text] [Related]

  • 2. Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.
    Jones RN, Erwin ME.
    Diagn Microbiol Infect Dis; 1992 Apr; 15(8):693-701. PubMed ID: 1478050
    [Abstract] [Full Text] [Related]

  • 3. In-vitro activity of cefpodoxime against pathogens responsible for community-acquired respiratory tract infections.
    Dabernat H, Avril JL, Boussougant Y.
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():1-6. PubMed ID: 2127267
    [Abstract] [Full Text] [Related]

  • 4. Pharmacodynamic activity of five oral cephalosporins against Haemophilus influenzae.
    Stein GE, Schooley S, Walker RD, Strenkoski-Nix L.
    Pharmacotherapy; 1997 Dec; 17(2):235-41. PubMed ID: 9085313
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro activity of second and third generation cephalosporins against ampicillin susceptible and resistant haemophilus influenzae.
    Burns JL, Wong K, Smith AL.
    Infection; 1988 Dec; 16(5):293-6. PubMed ID: 3265130
    [Abstract] [Full Text] [Related]

  • 7. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
    Wallrauch-Schwarz C, Milatovic D, Braveny I.
    Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nontypeable Haemophilus influenzae susceptibility: effect of inoculum size and beta-lactamase production.
    Gould JM, Heidecker GJ, LiPuma JJ.
    Diagn Microbiol Infect Dis; 1996 Oct; 26(2):95-8. PubMed ID: 8985663
    [Abstract] [Full Text] [Related]

  • 12. [Activity of cefpodoxime and other oral beta-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin].
    Fenoll A, Robledo O, Lerma M, Giménez MJ, Cebrián L, Casal J, Aguilar L, Gómez-Lus ML.
    Rev Esp Quimioter; 2006 Mar; 19(1):39-44. PubMed ID: 16688290
    [Abstract] [Full Text] [Related]

  • 13. In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin.
    Clark C, Bozdogan B, Peric M, Dewasse B, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2956-62. PubMed ID: 12183253
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative activities of moxalactam (LY 127935) a new semisynthetic 1-oxa-beta lactam antibiotic with 7 other antibiotics against type b Haemophilus influenzae.
    Chu ML, Harms JL, Liu C.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Sep; 14(3):146-55. PubMed ID: 6456875
    [Abstract] [Full Text] [Related]

  • 17. Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin.
    Bergeron MG, Claveau S, Simard P.
    Antimicrob Agents Chemother; 1981 Jan; 19(1):101-5. PubMed ID: 6454379
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].
    Dubreuil L, Derriennic M, Sedallian A.
    Pathol Biol (Paris); 1990 May; 38(5):343-6. PubMed ID: 2367150
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of cefpodoxime and ten other cephalosporins against gram-positive cocci, Enterobacteriaceae and Pseudomonas aeruginosa, including beta-lactamase producers.
    Wiedemann B, Luhmer E, Zühlsdorf MT.
    Infection; 1991 May; 19(5):363-9. PubMed ID: 1800378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.